Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN-103)

Conditions: Pre-Exposure Prophylaxis of HIV Infection Interventions: Drug: Lenacapavir Injection; Drug: Lenacapavir Tablet; Drug: Emtricitabine/tenofovir disoproxil fumarate (F/TDF) Sponsors: Gilead Sciences; HIV Prevention Trials Network; National Institute on Drug Abuse (NIDA); National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials